Tenaya Therapeutics (TNYA) Earnings Date & Reports

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

TNYA is expected to report earnings to fall 48.55% to -10 cents per share on November 11

Tenaya Therapeutics TNYA Stock Earnings Reports

Q3'26

Est.

$-0.10

Q2'26

Missed

by $0.14

Q1'26

Est.

$-0.09

Q4'25

Est.

$-0.12

Q3'25

Beat

by $0.03

The last earnings report on August 05 showed earnings per share of -20 cents, missing the estimate of -5 cents. With 2.84M shares outstanding, the current market capitalization sits at 132.25M.

View a ticker or compare two or three

TNYA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for TNYA